Factors | Patients (N) | SMGC | P value | |
---|---|---|---|---|
Early | Advanced | |||
Gender | 0.088# | |||
Male | 45 | 13 | 32 | |
Female | 12 | 7 | 5 | |
Age (years) | 0.121 | |||
< 65 | 32 | 14 | 18 | |
≥65 | 25 | 6 | 19 | |
Postoperative hospital stay, median (range, day) | – | 12(9-18) | 13(8-55) | 0.298 |
Surgical methods | 0.018*# | |||
B I | 11 | 8 | 3 | |
DG + R-Y | 9 | 3 | 6 | |
TG + R-Y | 37 | 9 | 28 | |
BMI, median (range, kg/m2) | – | 21.5 (17.3–26.6) | 22.3 (17.6–30.5) | 0.2919 |
Hypertension | 1.000# | |||
Yes | 12 | 4 | 8 | |
None | 45 | 16 | 29 | |
Diabetes | 0.607# | |||
Yes | 4 | 2 | 2 | |
None | 53 | 18 | 35 | |
Number of primary tumors | 0.100# | |||
Two | 52 | 18 | 34 | |
Three | 3 | 0 | 3 | |
Four | 2 | 2 | 0 | |
Tumor size | 0.012*# | |||
< 2 cm | 4 | 4 | 0 | |
≥2 cm | 53 | 16 | 37 | |
Histological type (Adenocarcinoma)a | 0.011*# | |||
Well-differentiated | 11 | 8 | 3 | |
Poorly differentiated | 46 | 12 | 34 | |
Consistency of histology | 0.174 | |||
Positive | 33 | 14 | 19 | |
Negative | 24 | 6 | 18 | |
Lymph node metastasis | 0.002* | |||
Yes | 24 | 3 | 21 | |
None | 33 | 17 | 16 | |
Ulcer | 0.012*# | |||
Positive | 53 | 16 | 37 | |
Negative | 4 | 4 | 0 | |
Lymphovascular cancer plug | 0.111# | |||
Positive | 13 | 2 | 11 | |
Negative | 44 | 18 | 26 | |
Nerve invasion | 0.001*# | |||
Positive | 14 | 0 | 14 | |
Negative | 43 | 20 | 23 | |
Preoperative CEA, median (range, ng/ml) | – | 2.08 (0.848–4.7) | 2.75 (0.2–23.5) | 0.0384* |
Preoperative CA19-9, median (range, U/ml) | – | 11.035 (0.6–43.2) | 10.1 (1.28–173.6) | 0.453 |
Preoperative AFP, median (range, ng/ml) | – | 2.755 (0.947–4.61) | 2.66 (1.05–8.25) | 0.3063 |
Preoperative CA153, median (range, U/ml) | – | 7.79 (3.44–20.6) | 8.99 (4.9–20.82) | 0.7443 |
Preoperative CA125, median (range, U/ml) | – | 10.91 (5.51–19.51) | 11.42 (3.28–39.09) | 0.2492 |
Preoperative CA724, median (range, U/ml) | – | 1.545 (0.2–8.35) | 1.95 (0.699–141.1) | 0.4754 |
Operation time, median (range, minute) | – | 158 (90–262) | 168 (102–340) | 0.6577 |
Postoperative complication | 0.545# | |||
Yes | 3 | 0 | 3 | |
None | 54 | 20 | 34 | |
Recurrence | 0.222# | |||
Yes | 8 | 1 | 7 | |
None | 34 | 14 | 20 | |
Total | 57 | 20 | 37 |